Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

31°

Site search

Home
News
- Local News
Sports
Obituaries
e-Edition
Classifieds
Explore the Sheyenne
Archives
Best of 2025
2026 Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Immutep Limited - American Depositary Shares (NQ:IMMP)

2.810 +0.320 (+12.85%)

Streaming Delayed Price Updated: 10:37 AM EST, Dec 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immutep Limited - American Depositary Shares

< Previous 1 2 3 Next >

SurgePays (NASDAQ: SURG) Expands Growth Strategy – New Lead-Driver to Boost Fintech Revenue – More Stocks Inside

December 09, 2025

Via AB Newswire

Topics Artificial Intelligence

What's going on in today's session ↗

December 08, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

December 08, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa

December 08, 2025

From Immutep Limited

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 13, 2025

Via Benzinga

Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer

October 09, 2025

From Immutep Limited

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 21, 2025

Via Benzinga

Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo ↗

May 15, 2025

Immutep's efti combo with Keytruda and chemo shows a 60.8% response rate in lung cancer trial, with strong efficacy across PD-L1 expression levels.

Via Benzinga

Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer

May 15, 2025

From Immutep Limited

Via GlobeNewswire

Unusual volume stocks in Wednesday's session ↗

May 07, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

May 06, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 05, 2025

Via Benzinga

Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial ↗

November 14, 2024

Immutep's INSIGHT-003 Phase 1 trial reports promising survival data for 1L NSCLC treatment using eftilagimod alpha, Keytruda, and chemotherapy.

Via Benzinga

Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer

November 14, 2024

From Immutep Limited

Via GlobeNewswire

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September ↗

September 16, 2024

Via Benzinga

Topics Stocks

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 29, 2024

Via Benzinga

Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 12, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 12, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Via InvestorPlace

Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars ↗

July 12, 2024

Immutep announces results from Cohort B of the TACTI-003 Phase 2b trial. The combination of eftilagimod alfa and Merck's Keytruda shows a 35.5% ORR and 58.1% DCR in PD-L1 negative head and neck cancer...

Via Benzinga

Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 12, 2024

Via Benzinga

Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

June 27, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 27, 2024

Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 24, 2024

Via Benzinga

Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? ↗

April 24, 2024

Immutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line treatment of HNSCC patients without PD-L1 expression. Final data expected in H1 CY2024.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 24, 2024

Via Benzinga

Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B

April 24, 2024

From Immutep Limited

Via GlobeNewswire

Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why ↗

March 05, 2024

Immutep releases promising safety and efficacy data for 90mg eftilagimod alpha combined with paclitaxel in HR+/HER2- metastatic breast cancer. No serious adverse events were reported, and a 50% overall...

Via Benzinga

Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023

October 24, 2023

From Immutep Limited

Via GlobeNewswire

Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer

October 23, 2023

From Immutep Limited

Via GlobeNewswire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Entertainment
Local Events
Sports
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

times-online.com
146 Third St. N.E.
Valley City, ND 58072
Phone: 701-845-0463
Email: vctr@times-online.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Immutep Limited - American Depositary Shares (NQ:IMMP)

All News about Immutep Limited - American Depositary Shares

Sections

Services

Follow Us